Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000594287 | SCV000701708 | uncertain significance | not provided | 2016-10-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764590 | SCV000895685 | uncertain significance | Frank-Ter Haar syndrome | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000594287 | SCV002148953 | uncertain significance | not provided | 2021-08-31 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with glutamine at codon 698 of the SH3PXD2B protein (p.Arg698Gln). The arginine residue is weakly conserved and there is a small physicochemical difference between arginine and glutamine. This variant is present in population databases (rs144659619, ExAC 0.2%). This variant has not been reported in the literature in individuals affected with SH3PXD2B-related conditions. ClinVar contains an entry for this variant (Variation ID: 497282). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |